Ubs Asset Management Americas Inc Artivion, Inc. Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Artivion, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 340,887 shares of AORT stock, worth $9.64 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
340,887
Previous 215,219
58.39%
Holding current value
$9.64 Million
Previous $5.52 Million
64.38%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding AORT
# of Institutions
175Shares Held
36MCall Options Held
33KPut Options Held
900-
Black Rock Inc. New York, NY6.64MShares$188 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$79.2 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$79 Million1.94% of portfolio
-
Macquarie Group LTD Australia, C32.75MShares$77.6 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.45MShares$69.3 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.14B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...